Passiflora Incarnata Flower

Dosage for Passiflora Incarnata Flower varies significantly depending on the concentration of the extract and the specific condition being addressed. For Generalized Anxiety Disorder (GAD), healthcare providers typically suggest a standardized extract of 400 mg to 900 mg daily, often divided into two or three doses. If using a liquid tincture (1:5 ratio), a common dose is 2 mL to 4 mL three times daily. For Insomnia, a single dose of 300 mg to 450 mg taken approximately 30 to 60 minutes before bedtime is common. If consumed as a tea, 0.5g to 2g of the dried herb steeped in 150mL of water may be used up to three times per day. Because these products are often non-standardized, it is vital to follow the specific labeling on the product or the instructions provided by a qualified healthcare professional.

Passiflora Incarnata Flower is not routinely recommended for use in children under the age of 12 due to a lack of robust safety data and clinical trials in this population. Some traditional practices use lower doses for children (e.g., 100 mg to 200 mg), but this should never be initiated without the direct supervision of a pediatrician. The risk of paradoxical excitation or excessive sedation is higher in pediatric patients. If a healthcare provider determines the benefit outweighs the risk, they will calculate a weight-based or age-based dose specifically for the child.

Renal Impairment

Data regarding the use of Passiflora in patients with kidney disease is limited. Since metabolites are primarily cleared through the kidneys, patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use this substance with extreme caution. A dose reduction of 50% may be considered by a healthcare provider to prevent accumulation and excessive CNS depression.

Hepatic Impairment

Because the liver is the primary site for the conjugation of flavonoids and alkaloids, patients with hepatic insufficiency (Child-Pugh Class B or C) should avoid high doses. Impaired metabolism can lead to increased plasma levels and a higher risk of side effects such as dizziness or confusion.

Elderly Patients

Geriatric patients are more sensitive to the CNS effects of GABAergic substances. Healthcare providers generally recommend starting at the lowest possible dose (e.g., 100 mg to 200 mg) to minimize the risk of ataxia (loss of coordination), falls, and cognitive impairment.

Passiflora Incarnata can be taken with or without food. However, taking it with a light meal may reduce the risk of gastrointestinal upset.

• Tablets/Capsules: Should be swallowed whole with a full glass of water. Do not crush or chew unless the formulation is specifically designed as a chewable tablet.
• Liquid Tinctures: These can be taken directly or mixed into a small amount of water or juice to mask the bitter taste.
• Storage: Store all forms in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to prevent accidental ingestion.

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of excessive sedation.

Signs of an overdose of Passiflora Incarnata Flower include extreme drowsiness, lethargy, muscle weakness, and slowed heart rate (bradycardia). In severe cases, it may lead to CNS depression. If an overdose is suspected, contact a poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on maintaining respiratory function and hydration.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

The most frequently reported side effect of Passiflora Incarnata Flower is somnolence (drowsiness). Patients often describe a feeling of heaviness or a strong urge to sleep shortly after administration. This effect is dose-dependent and typically lasts for 4 to 6 hours. Other common effects include:

• Dizziness: A sensation of lightheadedness or spinning, especially when rising from a seated position.
• Mild Ataxia: A slight lack of voluntary coordination of muscle movements, which may feel like clumsiness.
• Gastrointestinal Upset: Including mild nausea, abdominal cramping, or a feeling of fullness.

• Confusion: Some patients, particularly the elderly, may experience brief periods of mental clouding or difficulty concentrating.
• Tachycardia: An abnormally rapid heart rate has been reported in a small percentage of users, possibly as a paradoxical reaction.
• Headache: A dull, aching sensation that typically resolves as the body adjusts to the supplement.

• Hypersensitivity Reactions: Skin rashes, itching, or hives (urticaria).
• Vasculitis: There have been isolated case reports of inflammation of the blood vessels associated with Passiflora use, though a direct causal link is rare.
• Altered Consciousness: Rare reports of significant lethargy or 'dream-like' states.

> Warning: Stop taking Passiflora Incarnata Flower and call your doctor immediately if you experience any of these.

• Anaphylaxis: Signs include swelling of the face, lips, or throat; difficulty breathing; and a rapid drop in blood pressure. This is a life-threatening emergency.
• Severe Bradycardia: A dangerously slow heart rate that may cause fainting (syncope) or extreme fatigue.
• Hepatotoxicity Signs: Although rare, yellowing of the skin or eyes (jaundice), dark urine, or severe right-sided abdominal pain should be reported immediately.
• Severe Vasculitis: Painful, purple spots on the skin or joint pain that may indicate a systemic inflammatory response.

Data on the long-term use (greater than 8 weeks) of Passiflora Incarnata Flower is sparse. Potential long-term effects may include:

• Tolerance: The body may become accustomed to the sedative effects, requiring higher doses to achieve the same result.
• Psychological Dependence: While not physically addictive like benzodiazepines, individuals may feel they cannot sleep or manage anxiety without the supplement.
• Chronic Fatigue: Prolonged use may lead to a persistent feeling of tiredness or 'brain fog.'

There are currently no FDA black box warnings for Passiflora Incarnata Flower. However, because it is often sold as a dietary supplement, the FDA does not evaluate its safety and efficacy with the same rigor as prescription medications. Patients should remain vigilant for any unusual symptoms.

Report any unusual symptoms to your healthcare provider.

Passiflora Incarnata Flower is generally considered safe for short-term use in healthy adults. However, because it acts as a central nervous system (CNS) depressant, it must be used with caution. Patients should be aware that the potency of botanical extracts can vary significantly between brands, leading to unpredictable effects. Always inform your healthcare team of all supplements you are taking, especially before undergoing any medical procedures.

No FDA black box warnings for Passiflora Incarnata Flower.

• Allergic Reactions / Anaphylaxis Risk: Individuals with known allergies to plants in the Passifloraceae family should avoid this product. Because it is also used as an allergenic extract, those with severe environmental allergies may be at a higher risk for cross-reactivity.
• CNS Depression: Passiflora can significantly impair mental alertness and physical coordination. This effect is magnified when combined with other sedatives or alcohol.
• Surgery Precautions: Passiflora may increase the effects of anesthesia. The American Society of Anesthesiologists generally recommends discontinuing herbal supplements at least two weeks prior to scheduled surgery.
• Uterine Contractions: Some constituents of Passiflora, such as the harman alkaloids, have demonstrated uterine-stimulant properties in animal studies. This poses a potential risk for premature labor.

For short-term use, routine laboratory monitoring is typically not required. However, for individuals using Passiflora chronically or at high doses, healthcare providers may monitor:

• Liver Function Tests (LFTs): To ensure the liver is processing the alkaloids effectively.
• Complete Blood Count (CBC): To monitor for rare inflammatory or hematological changes.
• Clinical Assessment of Anxiety/Sleep: To evaluate the ongoing necessity of the supplement.

Do not drive, operate heavy machinery, or engage in hazardous activities until you know how Passiflora Incarnata Flower affects you. The sedative effects can be profound and may impair your reaction time and judgment. This impairment may persist into the morning if taken as a sleep aid the night before.

Alcohol should be strictly avoided while taking Passiflora Incarnata Flower. Alcohol synergistically increases the CNS depressant effects of the plant, which can lead to dangerous levels of respiratory depression, extreme dizziness, and loss of consciousness.

While Passiflora does not typically cause a severe withdrawal syndrome, it is advisable to taper the dose gradually if it has been used daily for several weeks. Abruptly stopping may result in 'rebound' anxiety or insomnia, where symptoms return more intensely than before.

> Important: Discuss all your medical conditions with your healthcare provider before starting Passiflora Incarnata Flower.

• MAO Inhibitors (MAOIs): Historically, Passiflora was thought to contain significant amounts of harmala alkaloids, which are MAO inhibitors. While modern extracts contain very low levels, combining Passiflora with prescription MAOIs (e.g., phenelzine, tranylcypromine) could theoretically lead to a hypertensive crisis or serotonin syndrome. This combination is generally contraindicated.
• CNS Depressants (High Dose): Do not use with potent sedatives like sodium oxybate due to the risk of profound respiratory depression.

• Benzodiazepines: Drugs like alprazolam (Xanax), lorazepam (Ativan), and diazepam (Valium) have additive effects with Passiflora. This can lead to excessive sedation, respiratory depression, and increased fall risk.
• Barbiturates: Passiflora may prolong the sleeping time induced by barbiturates (e.g., phenobarbital).
• Z-Drugs: Non-benzodiazepine hypnotics like zolpidem (Ambien) and eszopiclone (Lunesta) should be used with extreme caution alongside Passiflora.

• Anticoagulants and Antiplatelets: There is some evidence that Passiflora may have mild antiplatelet effects. When taken with drugs like warfarin (Coumadin), clopidogrel (Plavix), or aspirin, it may slightly increase the risk of bruising or bleeding.
• Antihypertensives: Passiflora may have a mild blood pressure-lowering effect. Combining it with prescription blood pressure medications may cause hypotension (excessively low blood pressure), leading to dizziness or fainting.

• Alcohol: As noted, alcohol significantly enhances the sedative effects and should be avoided.
• Caffeine: High intake of caffeine (coffee, tea, energy drinks) may counteract the anxiolytic and sedative effects of Passiflora, rendering it less effective.

• Sedative Herbs: Combining Passiflora with other calming herbs like Valerian root, Kava, St. John's Wort, or Melatonin can cause additive CNS depression.
• 5-HTP: May increase the risk of serotonin-related side effects if the Passiflora extract contains significant harmala alkaloids.

Passiflora Incarnata Flower is not known to significantly interfere with most common laboratory tests (such as glucose or cholesterol panels). However, its use should be disclosed to a doctor if undergoing a Urine Drug Screen, as some botanical constituents can occasionally cause false-positive results in specific immunoassay tests for benzodiazepines, though this is rare.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

Passiflora Incarnata Flower must NEVER be used in the following circumstances:

1. 1Pregnancy: Passiflora is strictly contraindicated during pregnancy. The alkaloids harmine and harmaline are known uterine stimulants that can induce contractions and potentially lead to miscarriage or premature labor.
2. 2Hypersensitivity: Individuals with a documented severe allergy to Passiflora incarnata or any member of the Passifloraceae family must avoid use. Anaphylactic reactions have been documented.
3. 3Severe Hepatic Failure: Due to the liver's role in metabolizing the complex alkaloids and flavonoids, those with end-stage liver disease should not use this extract to avoid toxic accumulation.

Conditions requiring careful risk-benefit analysis by a healthcare provider include:

• Depression: Because Passiflora is a CNS depressant, it may exacerbate symptoms of clinical depression or lethargy in some patients.
• Upcoming Surgery: As previously mentioned, the potential for interaction with anesthesia requires discontinuation 14 days prior to surgery.
• Hypotension: Patients with chronically low blood pressure may experience symptomatic hypotension (dizziness, fainting) due to the mild vasodilatory effects of the flavonoids.

Patients who are allergic to other species of the Passionflower genus (such as Passiflora edulis) are highly likely to be cross-sensitive to Passiflora incarnata. Additionally, there is a theoretical risk of cross-reactivity in patients with latex-fruit syndrome, although clinical evidence for this specific link is limited.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Passiflora Incarnata Flower.

Passiflora Incarnata Flower is classified as Category X in the context of pregnancy by many herbal monographs, although it does not have an official FDA pregnancy letter category. Clinical data and animal studies indicate that the harmala alkaloids present in the plant can cause uterine contractions. Therefore, use during any trimester of pregnancy is considered unsafe and should be strictly avoided to prevent potential teratogenicity or pregnancy loss.

It is unknown if the active constituents of Passiflora Incarnata Flower pass into human breast milk. Due to the lack of safety data and the potential for the infant to experience excessive sedation or poor feeding, the use of Passiflora is generally not recommended for nursing mothers. Healthcare providers usually suggest safer, better-studied alternatives for anxiety or sleep during lactation.

As noted in the dosage section, Passiflora is not approved for use in infants or young children. In adolescents (ages 12-18), it may be used under strict medical supervision for short-term anxiety, but healthcare providers must monitor for paradoxical reactions, such as increased agitation or irritability, which are more common in younger populations.

Elderly patients (over 65 years of age) are at a significantly increased risk for adverse effects from Passiflora. Age-related declines in renal and hepatic clearance can lead to higher systemic exposure. The primary concern in this population is the risk of falls and fractures due to ataxia and sedation. Additionally, the risk of polypharmacy (taking multiple medications) increases the likelihood of drug-drug interactions. Geriatric use should always start at the lowest possible dose with frequent monitoring of cognitive status.

In patients with moderate to severe renal impairment, the excretion of flavonoid conjugates may be delayed. While specific GFR-based dosing tables do not exist for this botanical, a cautious approach is required. Patients on hemodialysis should avoid use unless specifically directed by their nephrologist, as the clearance of these complex molecules during dialysis is not well-characterized.

Patients with cirrhosis or other forms of chronic liver disease may have a reduced capacity to metabolize the harman alkaloids. This can lead to prolonged sedation and an increased risk of encephalopathy (brain dysfunction due to liver failure). Use is generally discouraged in patients with a Child-Pugh score of 7 or higher.

> Important: Special populations require individualized medical assessment.

Passiflora Incarnata Flower exerts its therapeutic effects primarily through the modulation of the GABAergic system. The extract contains a variety of bioactive compounds, but the flavonoids (such as chrysin) and the GABA amino acid itself (which is present in the plant) are thought to be the primary drivers of its anxiolytic activity.

1. 1GABA-A Receptor Binding: Chrysin binds to the benzodiazepine receptors on the GABA-A complex, enhancing the inhibitory effect of GABA. This leads to an influx of chloride ions into the neuron, causing hyperpolarization and making the neuron less likely to fire.
2. 2GABA Reuptake Inhibition: Studies suggest that Passiflora extracts may inhibit the reuptake of GABA into the presynaptic nerve terminals, thereby increasing the concentration of GABA available in the synaptic cleft.
3. 3MAO Inhibition: While present in very small amounts, the harmala alkaloids can inhibit the enzyme monoamine oxidase, which breaks down neurotransmitters like serotonin and dopamine, though this effect is likely negligible at standard oral doses.

• Onset of Action: For anxiolytic effects, onset typically occurs within 30 to 60 minutes of oral administration. For sleep, the peak effect is usually reached within 90 minutes.
• Duration: The clinical effects generally persist for 4 to 8 hours.
• Tolerance: Unlike synthetic GABA-A agonists, there is less evidence of rapid receptor downregulation, though long-term efficacy studies are lacking.

| Parameter | Value |

|---|---|

| Bioavailability | Low to Moderate (Highly variable by extract type) |

| Protein Binding | ~70% to 90% (primarily for flavonoids like Chrysin) |

| Half-life | 4 to 12 hours (constituent dependent) |

| Tmax | 1.5 to 2.5 hours |

| Metabolism | Hepatic (Phase II Glucuronidation) |

| Excretion | Renal (80%), Fecal (20%) |

• Molecular Formula: Varies (Complex mixture; Chrysin is C15H10O4)
• Molecular Weight: Chrysin is 254.24 g/mol
• Solubility: Flavonoids are poorly soluble in water; better solubility in ethanol or methanol.
• Structure: The flower contains a unique profile of C-glycosyl flavonoids, including vitexin, isovitexin, and orientin.

Passiflora Incarnata is categorized as a Non-Standardized Plant Allergenic Extract [EPC]. In a broader therapeutic context, it is considered an Anxiolytic and Sedative-Hypnotic Botanical. It shares similar properties with other GABA-modulating herbs like Valeriana officinalis and Melissa officinalis.